BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Butt AS, Sharif F, Abid S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon? World J Hepatol 2018; 10(2): 267-276 [PMID: 29527262 DOI: 10.4254/wjh.v10.i2.267]
URL: https://www.wjgnet.com/1948-5182/full/v10/i2/267.htm
Number Citing Articles
1
Somenath Acharya, Gautam Barik, Biyanka Sau, Mandira Chakraborty, Somosree Ghosh, Indranil Aich. EVALUATION OF A STRATEGY TO DETECT ACTIVE HCV INFECTION USING A COMBINATION OF ELISA & TRI DOT ASSAYINTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 79 doi: 10.36106/6502671
2
Chen-Jei Tai, Alagie Jassey, Ching-Hsuan Liu, Cheng-Jeng Tai, Christopher D. Richardson, Shu Hui Wong, Liang-Tzung Lin. Targeting Autophagy Augments Berberine-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNACells 2020; 9(4): 908 doi: 10.3390/cells9040908
3
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver diseaseCochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
4
Arati Mane, Jilian Sacks, Sadhya Sharma, Harpreet Singh, Alexandra Tejada-Strop, Saleem Kamili, Kartik Kacholia, Ritubhan Gautam, Madhuri Thakar, Radhey Shyam Gupta, Raman Gangakhedkar, Luzia Helena Carvalho. Evaluation of five rapid diagnostic tests for detection of antibodies to hepatitis C virus (HCV): A step towards scale-up of HCV screening efforts in IndiaPLOS ONE 2019; 14(1): e0210556 doi: 10.1371/journal.pone.0210556
5
Franco Dammacco, Gianfranco Lauletta, Sabino Russi, Patrizia Leone, Marco Tucci, Carlo Manno, Salvatore Monaco, Sergio Ferrari, Angelo Vacca, Vito Racanelli. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitisClinical and Experimental Medicine 2019; 19(1): 1 doi: 10.1007/s10238-018-0536-z
6
Ahmed Lasfar. Liver Cancer2018;  doi: 10.5772/intechopen.81720
7
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative reviewPanminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
8
Agostino Colli, Tin Nadarević, Damir Miletić, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-fetoprotein for the diagnosis of hepatocellular carcinomaCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD013346
9
Ahmed M. Mostafa, Hesham A. Saafan, Ahmed S. Al-Tawashi, Muhannad H. Kasem, Ahmed M. Alaa, Mahmoud M. Eltobgy, Ahmed S. Moubarak, Manar M. Gharib, Mohamed A. Awwad, Hazem M. Omar, Marwa O. El-Derany. Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patientsVirus Research 2021; 292: 198226 doi: 10.1016/j.virusres.2020.198226
10
Ghada M. Salum, Reham M. Dawood, Mai Abd el-Meguid, Noha E. Ibrahim, Ashraf O. Abdel Aziz, Mostafa K. El Awady. Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patientsGenes & Diseases 2020; 7(3): 392 doi: 10.1016/j.gendis.2019.05.004
11
Ivana Mikolasevic, Tajana F. Kanizaj, Dorotea Bozic, Petra Puz, Sanja S. Shapeski, Zeljko Puljiz, Delfa Radic-Kristo, Milos Lalovac, Maja Mijic, Bozena Delija, Toni Juric, Ivan Bogadi, Lucija Virovic-Jukic. Metabolism of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy: A Review of the LiteratureCurrent Drug Metabolism 2021; 22(2): 89 doi: 10.2174/1389200221999201214224126
12
Giovanni Galati, Moises Muley, Mauro Viganò, Massimo Iavarone, Alessandro Vitale, Chiara Dell’Unto, Quirino Lai, Giuseppe Cabibbo, Rodolfo Sacco, Erica Villa, Franco Trevisani. Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysisExpert Opinion on Drug Safety 2019; 18(7): 603 doi: 10.1080/14740338.2019.1617272